Therapeutic use of medical Cannabis in neurological diseases: a clinical update

被引:0
|
作者
Ute Hidding
Tina Mainka
Carsten Buhmann
机构
[1] University Clinic Hamburg-Eppendorf,Department of Neurology
[2] Department of Neurology and Experimental Neurology at the Charité,Berlin Institute of Health at Charité
[3] BIH Charité Clinician Scientist Program,BIH Biomedical Innovation Academy
关键词
Cannabinoids; THC; Neurological diseases; Neurology;
D O I
暂无
中图分类号
学科分类号
摘要
The use of medical Cannabis has increased in recent years due to changing legal circumstances in many countries. Approval exists only for a few neurological conditions such as rare forms of epilepsy or spasticity in multiple sclerosis. Beyond that, however, medical Cannabis is used for a wide range of neurological conditions and symptoms. In Germany, in parallel with new legislation that has simplified the prescription of medical Cannabis, an accompanying survey has been implemented for which initial data are now available. In this context, our review provides an overview of the evidence for the therapeutic use of medical Cannabis in neurology, the potential benefits, and side effects.
引用
收藏
页码:117 / 126
页数:9
相关论文
共 50 条
  • [1] Therapeutic use of medical Cannabis in neurological diseases: a clinical update
    Hidding, Ute
    Mainka, Tina
    Buhmann, Carsten
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (02) : 117 - 126
  • [2] Neurological Disorders in Medical Use of Cannabis: An Update
    Solimini, Renata
    Rotolo, Maria Concetta
    Pichini, Simona
    Pacifici, Roberta
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (05) : 527 - 533
  • [3] Regulatory status of pesticide residues in cannabis: Implications to medical use in neurological diseases
    Pinkhasova, Dorina V.
    Jameson, Laura E.
    Conrow, Kendra D.
    Simeone, Michael P.
    Davis, Allan Peter
    Wiegers, Thomas C.
    Mattingly, Carolyn J.
    Leung, Maxwell C. K.
    [J]. CURRENT RESEARCH IN TOXICOLOGY, 2021, 2 : 140 - 148
  • [4] Use of Medical Cannabis for Respiratory Diseases
    Pechlivanidou, Rouzana
    Antoniadis, Andonis
    [J]. PNEUMON, 2018, 31 (02) : 67 - 70
  • [5] Use of intravenous immunoglobulins in neurological diseases: An update
    Stangel, M.
    Gold, R.
    [J]. AKTUELLE NEUROLOGIE, 2007, 34 (06) : 342 - 347
  • [6] Medical cannabis use in older patients: Update on medical knowledge
    Beauchet, Olivier
    [J]. MATURITAS, 2018, 118 : 56 - 59
  • [7] Editorial: Cannabis: Neurological Correlates in Abuse and Medical Use
    Pichini, Simona
    Busardo, Francesco P.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (05) : 524 - 526
  • [8] Is the medical use of cannabis a therapeutic option for children?
    Rieder, Michael J.
    [J]. PAEDIATRICS & CHILD HEALTH, 2016, 21 (01) : 31 - 34
  • [9] Challenges and opportunities for therapeutic use of medical cannabis
    Sampaio, M. F. S.
    Trancoso, I.
    Coimbra, N. C.
    Pereira, M. G.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2024, 23 (01):
  • [10] THERAPEUTIC USE OF MEDICINAL CANNABIS IN PEOPLE WITH DEGENERATIVE NEUROLOGICAL DISEASE
    da Silva, Roni Robson
    da Silva, Leandro Andrade
    dos Santos, Luiz Otavio Pereira
    Ribeiro, Alexandro Alves
    Sales, Fabricia Martins
    Alencar, Icaro Ferracini
    [J]. REVISTA DE PESQUISA-CUIDADO E FUNDAMENTAL ONLINE, 2022, 14